11.90
0.68%
+0.08
After Hours:
11.90
R1 RCM Inc. stock is currently priced at $11.90, with a 24-hour trading volume of 1.47M.
It has seen a +0.68% increased in the last 24 hours and a -8.46% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $11.77 pivot point. If it approaches the $12.05 resistance level, significant changes may occur.
Previous Close:
$11.82
Open:
$11.77
24h Volume:
1.47M
Market Cap:
$5.01B
Revenue:
$2.25B
Net Income/Loss:
$3.30M
P/E Ratio:
-138.69
EPS:
-0.0858
Net Cash Flow:
$237.60M
1W Performance:
-0.75%
1M Performance:
-8.46%
6M Performance:
+6.73%
1Y Performance:
-21.76%
R1 RCM Inc. Stock (RCM) Company Profile
Name
R1 RCM Inc.
Sector
Industry
Phone
312-324-7820
Address
401 North Michigan Avenue, Suite 2700, Chicago, IL
R1 RCM Inc. Stock (RCM) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-03-24 | Initiated | Barclays | Overweight |
Dec-15-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Dec-13-23 | Downgrade | JP Morgan | Overweight → Neutral |
Oct-19-23 | Upgrade | Truist | Hold → Buy |
Sep-22-23 | Initiated | Citigroup | Buy |
Aug-15-23 | Initiated | Cantor Fitzgerald | Overweight |
Apr-12-23 | Initiated | Stephens | Overweight |
Apr-11-23 | Initiated | Robert W. Baird | Outperform |
Feb-02-23 | Downgrade | Truist | Buy → Hold |
Jan-05-23 | Initiated | Canaccord Genuity | Buy |
Dec-07-22 | Upgrade | Guggenheim | Neutral → Buy |
Dec-06-22 | Initiated | Morgan Stanley | Equal-Weight |
Oct-24-22 | Initiated | Evercore ISI | Outperform |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-07-22 | Initiated | Truist | Buy |
Aug-01-22 | Resumed | JP Morgan | Overweight |
Jun-29-22 | Resumed | Barclays | Overweight |
Apr-14-22 | Initiated | Guggenheim | Neutral |
Feb-09-22 | Initiated | Deutsche Bank | Buy |
Dec-02-21 | Initiated | Jefferies | Buy |
Oct-14-21 | Initiated | JP Morgan | Overweight |
Sep-30-21 | Initiated | Barclays | Overweight |
Jul-22-21 | Initiated | BofA Securities | Buy |
Jun-02-21 | Initiated | Robert W. Baird | Outperform |
Aug-05-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
Apr-13-20 | Initiated | SVB Leerink | Mkt Perform |
Jan-14-20 | Reiterated | Dougherty & Company | Buy |
Jan-10-20 | Initiated | Dougherty & Company | Buy |
Jan-22-19 | Initiated | KeyBanc Capital Mkts | Overweight |
Dec-10-18 | Initiated | Citigroup | Buy |
Sep-04-18 | Initiated | Chardan Capital Markets | Buy |
Apr-09-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
View All
R1 RCM Inc. Stock (RCM) Latest News
The Latest Analyst Ratings For R1 RCM
Benzinga
R1 RCM to Release First Quarter 2024 Results on May 8, 2024
GlobeNewswire Inc.
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report
GlobeNewswire Inc.
Analyst Scoreboard: 12 Ratings For R1 RCM
Benzinga
New Strong Sell Stocks for March 12th
Zacks Investment Research
Alphabet, Dover And 2 Other Stocks Insiders Are Selling
Benzinga
R1 RCM Inc. Stock (RCM) Financials Data
R1 RCM Inc. (RCM) Revenue 2024
RCM reported a revenue (TTM) of $2.25 billion for the quarter ending December 31, 2023, a +24.79% rise year-over-year.
R1 RCM Inc. (RCM) Net Income 2024
RCM net income (TTM) was $3.30 million for the quarter ending December 31, 2023, a +105.21% increase year-over-year.
R1 RCM Inc. (RCM) Cash Flow 2024
RCM recorded a free cash flow (TTM) of $237.60 million for the quarter ending December 31, 2023, a +329.79% increase year-over-year.
R1 RCM Inc. (RCM) Earnings per Share 2024
RCM earnings per share (TTM) was $0.0095 for the quarter ending December 31, 2023, a +105.94% growth year-over-year.
R1 RCM Inc. Stock (RCM) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
SPARBY JOHN M. | President |
Mar 07 '24 |
Sale |
14.33 |
10,046 |
143,959 |
0 |
HENNEMAN JOHN B III | Director |
Aug 08 '23 |
Option Exercise |
2.61 |
50,000 |
130,500 |
122,114 |
HENNEMAN JOHN B III | Director |
Aug 08 '23 |
Sale |
17.17 |
50,000 |
858,650 |
72,114 |
Evans Richard B. Jr. | Principal Accounting Officer |
Jun 12 '23 |
Sale |
16.84 |
17,000 |
286,229 |
124,007 |
Evans Richard B. Jr. | Principal Accounting Officer |
Jun 09 '23 |
Sale |
16.69 |
12,000 |
200,280 |
141,007 |
SPARBY JOHN M. | President |
May 10 '23 |
Sale |
16.36 |
20,000 |
327,280 |
243,827 |
About R1 RCM Inc.
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides modular services comprising physician advisory services, which assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; and revenue capture services, including charge capture, charge description master maintenance, and pricing services. It serves single or multi-hospital healthcare systems, and their respective affiliated ambulatory clinics and physician practice groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is headquartered in Chicago, Illinois.
Cap:
|
Volume (24h):